2018
DOI: 10.1016/s0016-5085(18)30517-1
|View full text |Cite
|
Sign up to set email alerts
|

28 - Fecal Microbiota Transplant Versus Antibiotics for Primary Clostridium Difficile Infection – a Multicenter, Randomized Proof-of-Concept Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In human medical practice after the patients were treated with wide spectrum antibiotics the microbiome vanishes and they become susceptible to the aggressive and dangerous gut pathogen Clostridium difficile. The most effective treatment of this condition is the faecal transplantation from a healthy human donor (Juul et al, 2018). Other experiments indicate that upon infection of a resistant host animal, through the replacement of its microbiome with another, susceptible mouse's microbiome, these animals can be effectively infected by the pathogen too (Willing et al, 2011).…”
Section: Microbiome Succession Is Facilitated By Bacterial Conjugatio...mentioning
confidence: 99%
“…In human medical practice after the patients were treated with wide spectrum antibiotics the microbiome vanishes and they become susceptible to the aggressive and dangerous gut pathogen Clostridium difficile. The most effective treatment of this condition is the faecal transplantation from a healthy human donor (Juul et al, 2018). Other experiments indicate that upon infection of a resistant host animal, through the replacement of its microbiome with another, susceptible mouse's microbiome, these animals can be effectively infected by the pathogen too (Willing et al, 2011).…”
Section: Microbiome Succession Is Facilitated By Bacterial Conjugatio...mentioning
confidence: 99%
“…In patients with long-term use of antibiotics or low immunity, the balance of intestinal flora is disrupted, such that C. difficile adheres to host intestinal epithelial cells, rapidly proliferates the intestinal niche, and produces toxins, such as C. difficile toxin A [TcdA] and C. difficile toxin B [TcdB] as well as binary toxins. These toxins trigger a cascade of cellular events that lead to fluid secretion, inflammation, and tissue damage, which bring about the symptoms of C. difficile infection (CDI), such as pseudomembranous colitis, toxic megacolon, and even death (Juul et al, 2018;Zhou et al, 2019;Rao and Malani, 2020).…”
Section: Introductionmentioning
confidence: 99%